Literature DB >> 22200825

Prostate cancer: androgen deprivation causes EMT in the prostate.

Melanie Clyne.   

Abstract

Entities:  

Year:  2011        PMID： 22200825     DOI： 10.1038/nrurol.2011.208

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapy.

Authors:  Yuting Sun; Bu-Er Wang; Kevin G Leong; Peng Yue; Li Li; Suchit Jhunjhunwala; Darrell Chen; Kyounghee Seo; Zora Modrusan; Wei-Qiang Gao; Jeffrey Settleman; Leisa Johnson
Journal:  Cancer Res       Date:  2011-11-22       Impact factor: 12.701
  1 in total
  6 in total

1.  A novel anti‑cancer effect of resveratrol: reversal of epithelial‑mesenchymal transition in prostate cancer cells.

Authors:  Jianping Li; Tie Chong; Ziming Wang; Haiwen Chen; Hecheng Li; Jun Cao; Peng Zhang; Hongliang Li
Journal:  Mol Med Rep       Date:  2014-07-23       Impact factor: 2.952

2.  Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer.

Authors:  Yoshiyuki Okada; Masahiro Sonoshita; Fumihiko Kakizaki; Naoki Aoyama; Yoshiro Itatani; Masayuki Uegaki; Hiromasa Sakamoto; Takashi Kobayashi; Takahiro Inoue; Tomomi Kamba; Akira Suzuki; Osamu Ogawa; M Mark Taketo
Journal:  Cancer Sci       Date:  2017-04-12       Impact factor: 6.716

3.  LncRNA SNHG9 is a prognostic biomarker and correlated with immune infiltrates in prostate cancer.

Authors:  Chao Li; Jiao Hu; Xiheng Hu; Cheng Zhao; Miao Mo; Xiongbing Zu; Yangle Li
Journal:  Transl Androl Urol       Date:  2021-01

4.  Patient-derived tissue slice grafts accurately depict response of high-risk primary prostate cancer to androgen deprivation therapy.

Authors:  Hongjuan Zhao; Alan Thong; Rosalie Nolley; Stephen W Reese; Jennifer Santos; Alexandre Ingels; Donna M Peehl
Journal:  J Transl Med       Date:  2013-08-28       Impact factor: 5.531

5.  Over-expression of a poor prognostic marker in prostate cancer: AQP5 promotes cells growth and local invasion.

Authors:  Jianping Li; Ziming Wang; Tie Chong; Haiwen Chen; Hechen Li; Gang Li; Xiaoqiang Zhai; Youfang Li
Journal:  World J Surg Oncol       Date:  2014-09-13       Impact factor: 2.754

Review 6.  B lymphoma Moloney murine leukemia virus insertion region 1: An oncogenic mediator in prostate cancer.

Authors:  Qipeng Liu; Qiaqia Li; Sen Zhu; Yang Yi; Qi Cao
Journal:  Asian J Androl       Date:  2019 May-Jun       Impact factor: 3.285
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.